Tourette syndrome
Tourette syndrome supports educational organizations in delivering independent education on assessment, treatment, and coordinated care to improve healthcare professionals’ understanding of the condition.
Funder: Teva
Due Dates: At least 60 days before the required decision date | At least 60 days before activity start (completed request)
Funding Amounts: Not specified
Summary: Supports education on Tourette syndrome assessment, treatment, individualized management, and multidisciplinary care coordination.
Key Information: Grants support educational organizations, not individuals, including individual healthcare professionals.
Description
Teva supports independent education that improves healthcare professionals’ understanding of Tourette syndrome and care across its clinical course. Priorities include pathophysiology and disease burden, including effects on functioning, quality of life, psychosocial well-being, academic performance, and daily activities. Education should strengthen competence in guideline-driven diagnosis, assessment, and monitoring of tic disorders, including severity, symptom burden, and functional impairment.
The program also supports education on current and emerging treatments, individualized treatment planning, patient and caregiver education, shared decision-making, and multidisciplinary care coordination across specialties and settings. Its intended audience includes pediatric neurologists, pediatric psychiatrists, movement disorder specialists, pediatricians, nurse practitioners, physician assistants, nurses, and pharmacists.
